nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenhydramine—CYP2C18—malignant glioma	0.391	0.448	CbGaD
Diphenhydramine—CYP2B6—malignant glioma	0.291	0.333	CbGaD
Diphenhydramine—PTGS1—malignant glioma	0.191	0.219	CbGaD
Diphenhydramine—CYP1A2—Carmustine—malignant glioma	0.0363	1	CbGbCtD
Diphenhydramine—Nasal congestion—Temozolomide—malignant glioma	0.000504	0.0351	CcSEcCtD
Diphenhydramine—Diplopia—Carmustine—malignant glioma	0.000475	0.0331	CcSEcCtD
Diphenhydramine—Diplopia—Temozolomide—malignant glioma	0.000459	0.032	CcSEcCtD
Diphenhydramine—Benzphetamine—POR—malignant glioma	0.000458	0.0696	CrCbGaD
Diphenhydramine—Sweating increased—Temozolomide—malignant glioma	0.000386	0.0269	CcSEcCtD
Diphenhydramine—Dysuria—Temozolomide—malignant glioma	0.000371	0.0258	CcSEcCtD
Diphenhydramine—Pollakiuria—Temozolomide—malignant glioma	0.000366	0.0255	CcSEcCtD
Diphenhydramine—Amitriptyline—NTRK2—malignant glioma	0.000363	0.0552	CrCbGaD
Diphenhydramine—Photosensitivity reaction—Temozolomide—malignant glioma	0.000362	0.0252	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Carmustine—malignant glioma	0.000359	0.025	CcSEcCtD
Diphenhydramine—Neuropathy peripheral—Temozolomide—malignant glioma	0.000347	0.0241	CcSEcCtD
Diphenhydramine—Cyclopentolate—BCHE—malignant glioma	0.000339	0.0515	CrCbGaD
Diphenhydramine—Warfarin—CYP2C18—malignant glioma	0.00031	0.0472	CrCbGaD
Diphenhydramine—Tinnitus—Temozolomide—malignant glioma	0.000296	0.0206	CcSEcCtD
Diphenhydramine—Bifonazole—CYP2B6—malignant glioma	0.000287	0.0436	CrCbGaD
Diphenhydramine—Chills—Temozolomide—malignant glioma	0.000285	0.0198	CcSEcCtD
Diphenhydramine—Diphenylpyraline—SLC6A3—malignant glioma	0.000283	0.043	CrCbGaD
Diphenhydramine—Vision blurred—Carmustine—malignant glioma	0.00027	0.0188	CcSEcCtD
Diphenhydramine—Tremor—Carmustine—malignant glioma	0.000268	0.0187	CcSEcCtD
Diphenhydramine—Agitation—Carmustine—malignant glioma	0.000263	0.0183	CcSEcCtD
Diphenhydramine—Vision blurred—Temozolomide—malignant glioma	0.00026	0.0181	CcSEcCtD
Diphenhydramine—Tremor—Temozolomide—malignant glioma	0.000259	0.018	CcSEcCtD
Diphenhydramine—Agitation—Temozolomide—malignant glioma	0.000254	0.0177	CcSEcCtD
Diphenhydramine—Vertigo—Temozolomide—malignant glioma	0.000248	0.0173	CcSEcCtD
Diphenhydramine—Convulsion—Carmustine—malignant glioma	0.000248	0.0173	CcSEcCtD
Diphenhydramine—Palpitations—Temozolomide—malignant glioma	0.000244	0.017	CcSEcCtD
Diphenhydramine—Oxaprozin—PTGS1—malignant glioma	0.00024	0.0364	CrCbGaD
Diphenhydramine—Convulsion—Temozolomide—malignant glioma	0.000239	0.0167	CcSEcCtD
Diphenhydramine—Confusional state—Carmustine—malignant glioma	0.000235	0.0164	CcSEcCtD
Diphenhydramine—Dry mouth—Temozolomide—malignant glioma	0.00023	0.016	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Carmustine—malignant glioma	0.000229	0.0159	CcSEcCtD
Diphenhydramine—Tachycardia—Carmustine—malignant glioma	0.000228	0.0159	CcSEcCtD
Diphenhydramine—Confusional state—Temozolomide—malignant glioma	0.000227	0.0158	CcSEcCtD
Diphenhydramine—Carbinoxamine—CYP2B6—malignant glioma	0.000227	0.0345	CrCbGaD
Diphenhydramine—Phenytoin—CYP2C18—malignant glioma	0.000225	0.0343	CrCbGaD
Diphenhydramine—Amitriptyline—NTRK1—malignant glioma	0.000224	0.0341	CrCbGaD
Diphenhydramine—Anorexia—Carmustine—malignant glioma	0.000222	0.0155	CcSEcCtD
Diphenhydramine—Thrombocytopenia—Temozolomide—malignant glioma	0.000221	0.0154	CcSEcCtD
Diphenhydramine—Hypotension—Carmustine—malignant glioma	0.000218	0.0152	CcSEcCtD
Diphenhydramine—Hyperhidrosis—Temozolomide—malignant glioma	0.000218	0.0152	CcSEcCtD
Diphenhydramine—Benzatropine—SLC6A3—malignant glioma	0.000217	0.033	CrCbGaD
Diphenhydramine—Anorexia—Temozolomide—malignant glioma	0.000215	0.015	CcSEcCtD
Diphenhydramine—Insomnia—Carmustine—malignant glioma	0.000211	0.0147	CcSEcCtD
Diphenhydramine—Paraesthesia—Carmustine—malignant glioma	0.00021	0.0146	CcSEcCtD
Diphenhydramine—Somnolence—Carmustine—malignant glioma	0.000208	0.0144	CcSEcCtD
Diphenhydramine—Insomnia—Temozolomide—malignant glioma	0.000204	0.0142	CcSEcCtD
Diphenhydramine—Decreased appetite—Carmustine—malignant glioma	0.000203	0.0141	CcSEcCtD
Diphenhydramine—Paraesthesia—Temozolomide—malignant glioma	0.000203	0.0141	CcSEcCtD
Diphenhydramine—Somnolence—Temozolomide—malignant glioma	0.000201	0.014	CcSEcCtD
Diphenhydramine—Constipation—Carmustine—malignant glioma	0.0002	0.0139	CcSEcCtD
Diphenhydramine—Dyspepsia—Temozolomide—malignant glioma	0.000199	0.0138	CcSEcCtD
Diphenhydramine—Fenoprofen—PTGS1—malignant glioma	0.000198	0.0301	CrCbGaD
Diphenhydramine—Brompheniramine—CYP2B6—malignant glioma	0.000197	0.0299	CrCbGaD
Diphenhydramine—Decreased appetite—Temozolomide—malignant glioma	0.000196	0.0137	CcSEcCtD
Diphenhydramine—Fatigue—Temozolomide—malignant glioma	0.000194	0.0135	CcSEcCtD
Diphenhydramine—Constipation—Temozolomide—malignant glioma	0.000193	0.0134	CcSEcCtD
Diphenhydramine—Feeling abnormal—Carmustine—malignant glioma	0.000192	0.0134	CcSEcCtD
Diphenhydramine—Modafinil—CYP2B6—malignant glioma	0.000189	0.0287	CrCbGaD
Diphenhydramine—Feeling abnormal—Temozolomide—malignant glioma	0.000186	0.0129	CcSEcCtD
Diphenhydramine—Cinnarizine—CYP2B6—malignant glioma	0.000182	0.0277	CrCbGaD
Diphenhydramine—Urticaria—Temozolomide—malignant glioma	0.000179	0.0125	CcSEcCtD
Diphenhydramine—Methadone—CYP2C18—malignant glioma	0.00017	0.0259	CrCbGaD
Diphenhydramine—Asthenia—Carmustine—malignant glioma	0.000167	0.0117	CcSEcCtD
Diphenhydramine—Phenytoin—CYP2B6—malignant glioma	0.000167	0.0254	CrCbGaD
Diphenhydramine—Chlorphenamine—SLC6A3—malignant glioma	0.000165	0.025	CrCbGaD
Diphenhydramine—Benzphetamine—CYP2B6—malignant glioma	0.000163	0.0249	CrCbGaD
Diphenhydramine—Asthenia—Temozolomide—malignant glioma	0.000162	0.0113	CcSEcCtD
Diphenhydramine—Modafinil—SLC6A3—malignant glioma	0.000161	0.0244	CrCbGaD
Diphenhydramine—Diarrhoea—Carmustine—malignant glioma	0.00016	0.0111	CcSEcCtD
Diphenhydramine—Phenylbutazone—PTGS1—malignant glioma	0.000158	0.0241	CrCbGaD
Diphenhydramine—Dizziness—Carmustine—malignant glioma	0.000154	0.0107	CcSEcCtD
Diphenhydramine—Diarrhoea—Temozolomide—malignant glioma	0.000154	0.0107	CcSEcCtD
Diphenhydramine—Dizziness—Temozolomide—malignant glioma	0.000149	0.0104	CcSEcCtD
Diphenhydramine—Vomiting—Carmustine—malignant glioma	0.000148	0.0103	CcSEcCtD
Diphenhydramine—Rash—Carmustine—malignant glioma	0.000147	0.0102	CcSEcCtD
Diphenhydramine—Dermatitis—Carmustine—malignant glioma	0.000147	0.0102	CcSEcCtD
Diphenhydramine—Headache—Carmustine—malignant glioma	0.000146	0.0102	CcSEcCtD
Diphenhydramine—Vomiting—Temozolomide—malignant glioma	0.000143	0.00999	CcSEcCtD
Diphenhydramine—Rash—Temozolomide—malignant glioma	0.000142	0.0099	CcSEcCtD
Diphenhydramine—Dermatitis—Temozolomide—malignant glioma	0.000142	0.00989	CcSEcCtD
Diphenhydramine—Headache—Temozolomide—malignant glioma	0.000141	0.00984	CcSEcCtD
Diphenhydramine—Benzphetamine—SLC6A3—malignant glioma	0.000139	0.0212	CrCbGaD
Diphenhydramine—Nausea—Carmustine—malignant glioma	0.000139	0.00965	CcSEcCtD
Diphenhydramine—Atomoxetine—SLC6A3—malignant glioma	0.000138	0.021	CrCbGaD
Diphenhydramine—Oxaprozin—PTGS2—malignant glioma	0.000137	0.0208	CrCbGaD
Diphenhydramine—Nausea—Temozolomide—malignant glioma	0.000134	0.00933	CcSEcCtD
Diphenhydramine—Imipramine—CYP2C18—malignant glioma	0.000133	0.0203	CrCbGaD
Diphenhydramine—Promethazine—CYP2B6—malignant glioma	0.000128	0.0195	CrCbGaD
Diphenhydramine—Tamoxifen—CYP2B6—malignant glioma	0.000128	0.0194	CrCbGaD
Diphenhydramine—Methadone—CYP2B6—malignant glioma	0.000126	0.0192	CrCbGaD
Diphenhydramine—Orphenadrine—CYP2B6—malignant glioma	0.000124	0.0188	CrCbGaD
Diphenhydramine—Trimipramine—SLC6A3—malignant glioma	0.000114	0.0173	CrCbGaD
Diphenhydramine—Fenoprofen—PTGS2—malignant glioma	0.000113	0.0172	CrCbGaD
Diphenhydramine—Imipramine—CYP2B6—malignant glioma	9.89e-05	0.015	CrCbGaD
Diphenhydramine—Amitriptyline—CYP2B6—malignant glioma	9.83e-05	0.015	CrCbGaD
Diphenhydramine—Phenylbutazone—PTGS2—malignant glioma	9.05e-05	0.0138	CrCbGaD
Diphenhydramine—Imipramine—SLC6A3—malignant glioma	8.43e-05	0.0128	CrCbGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PIK3CD—malignant glioma	1.08e-05	0.000154	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SPHK1—malignant glioma	1.07e-05	0.000154	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PIK3CB—malignant glioma	1.06e-05	0.000153	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KNG1—malignant glioma	1.06e-05	0.000152	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.06e-05	0.000151	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PTGS2—malignant glioma	1.05e-05	0.000151	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CYP2C18—malignant glioma	1.05e-05	0.000151	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—AKT2—malignant glioma	1.03e-05	0.000148	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NTRK1—malignant glioma	1.03e-05	0.000147	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTGS1—malignant glioma	1.02e-05	0.000146	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.02e-05	0.000146	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.02e-05	0.000146	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—AKT2—malignant glioma	1.02e-05	0.000146	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NTRK1—malignant glioma	1.01e-05	0.000145	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—CAV1—malignant glioma	1.01e-05	0.000145	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTT1—malignant glioma	1e-05	0.000144	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—GSTP1—malignant glioma	1e-05	0.000143	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTT1—malignant glioma	9.94e-06	0.000143	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CD—malignant glioma	9.94e-06	0.000142	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	9.91e-06	0.000142	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—CAV1—malignant glioma	9.82e-06	0.000141	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CD—malignant glioma	9.78e-06	0.00014	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CAT—malignant glioma	9.73e-06	0.00014	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MMP3—malignant glioma	9.56e-06	0.000137	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PIK3CB—malignant glioma	9.54e-06	0.000137	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—BCHE—malignant glioma	9.5e-06	0.000136	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CDKN2B—malignant glioma	9.48e-06	0.000136	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—CAV1—malignant glioma	9.43e-06	0.000135	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MMP3—malignant glioma	9.41e-06	0.000135	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTGS1—malignant glioma	9.4e-06	0.000135	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PIK3CB—malignant glioma	9.38e-06	0.000135	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—SLC5A5—malignant glioma	9.38e-06	0.000135	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	9.38e-06	0.000135	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CDKN2B—malignant glioma	9.33e-06	0.000134	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTGS1—malignant glioma	9.32e-06	0.000134	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	9.28e-06	0.000133	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CG—malignant glioma	9.22e-06	0.000132	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTK2—malignant glioma	9.21e-06	0.000132	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—NCOR1—malignant glioma	9.19e-06	0.000132	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PTEN—malignant glioma	9.19e-06	0.000132	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—CXCL8—malignant glioma	9.17e-06	0.000131	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTK2—malignant glioma	9.06e-06	0.00013	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HES1—malignant glioma	9.04e-06	0.00013	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	9.02e-06	0.000129	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—CXCL8—malignant glioma	9.02e-06	0.000129	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NCOR1—malignant glioma	8.99e-06	0.000129	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CG—malignant glioma	8.95e-06	0.000128	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HES1—malignant glioma	8.9e-06	0.000128	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PPARG—malignant glioma	8.89e-06	0.000128	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.87e-06	0.000127	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—RAF1—malignant glioma	8.87e-06	0.000127	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NCOR1—malignant glioma	8.85e-06	0.000127	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.79e-06	0.000126	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—IL2—malignant glioma	8.76e-06	0.000126	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—BCHE—malignant glioma	8.74e-06	0.000125	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—RAF1—malignant glioma	8.73e-06	0.000125	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	8.71e-06	0.000125	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—BCHE—malignant glioma	8.66e-06	0.000124	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CB—malignant glioma	8.66e-06	0.000124	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PPARG—malignant glioma	8.63e-06	0.000124	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—SLC5A5—malignant glioma	8.63e-06	0.000124	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—IL2—malignant glioma	8.62e-06	0.000124	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PDGFRA—malignant glioma	8.61e-06	0.000123	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CG—malignant glioma	8.59e-06	0.000123	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—SLC5A5—malignant glioma	8.56e-06	0.000123	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CB—malignant glioma	8.52e-06	0.000122	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTT1—malignant glioma	8.5e-06	0.000122	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PDGFRA—malignant glioma	8.47e-06	0.000121	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—SPP1—malignant glioma	8.36e-06	0.00012	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—CXCL8—malignant glioma	8.32e-06	0.000119	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PPARG—malignant glioma	8.29e-06	0.000119	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—SPP1—malignant glioma	8.23e-06	0.000118	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—CXCL8—malignant glioma	8.19e-06	0.000117	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CD—malignant glioma	8.1e-06	0.000116	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.09e-06	0.000116	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.02e-06	0.000115	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTGS1—malignant glioma	7.96e-06	0.000114	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—IL2—malignant glioma	7.95e-06	0.000114	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	7.93e-06	0.000114	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TERT—malignant glioma	7.92e-06	0.000114	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CD—malignant glioma	7.86e-06	0.000113	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—IL2—malignant glioma	7.83e-06	0.000112	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TERT—malignant glioma	7.8e-06	0.000112	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PDGFB—malignant glioma	7.74e-06	0.000111	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FGFR1—malignant glioma	7.69e-06	0.00011	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.67e-06	0.00011	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PDGFB—malignant glioma	7.61e-06	0.000109	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—HIF1A—malignant glioma	7.58e-06	0.000109	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FGFR1—malignant glioma	7.57e-06	0.000109	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—GSTP1—malignant glioma	7.56e-06	0.000108	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CD—malignant glioma	7.55e-06	0.000108	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—CAV1—malignant glioma	7.49e-06	0.000107	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—HIF1A—malignant glioma	7.46e-06	0.000107	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—BCHE—malignant glioma	7.4e-06	0.000106	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CAT—malignant glioma	7.36e-06	0.000105	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CAV1—malignant glioma	7.33e-06	0.000105	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—SLC5A5—malignant glioma	7.31e-06	0.000105	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KDR—malignant glioma	7.25e-06	0.000104	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CAV1—malignant glioma	7.21e-06	0.000103	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KDR—malignant glioma	7.13e-06	0.000102	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CB—malignant glioma	7.06e-06	0.000101	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTGS2—malignant glioma	7e-06	0.0001	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.99e-06	0.0001	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—F2—malignant glioma	6.98e-06	0.0001	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FN1—malignant glioma	6.98e-06	0.0001	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—GSTP1—malignant glioma	6.95e-06	9.97e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—NCOR1—malignant glioma	6.95e-06	9.96e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	6.91e-06	9.91e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—BAD—malignant glioma	6.89e-06	9.88e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—GSTP1—malignant glioma	6.89e-06	9.88e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—F2—malignant glioma	6.87e-06	9.84e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FN1—malignant glioma	6.87e-06	9.84e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CB—malignant glioma	6.86e-06	9.83e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	6.85e-06	9.82e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—NOTCH1—malignant glioma	6.83e-06	9.79e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CG—malignant glioma	6.83e-06	9.79e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTGS2—malignant glioma	6.79e-06	9.74e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—BAD—malignant glioma	6.78e-06	9.72e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CAT—malignant glioma	6.77e-06	9.7e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	6.72e-06	9.63e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CAT—malignant glioma	6.71e-06	9.61e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CD80—malignant glioma	6.69e-06	9.59e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—APC—malignant glioma	6.68e-06	9.57e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CG—malignant glioma	6.68e-06	9.57e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EGF—malignant glioma	6.6e-06	9.46e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PPARG—malignant glioma	6.59e-06	9.44e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CD80—malignant glioma	6.58e-06	9.44e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CB—malignant glioma	6.58e-06	9.43e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—APC—malignant glioma	6.57e-06	9.42e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	6.57e-06	9.42e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTPN11—malignant glioma	6.56e-06	9.4e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTGS2—malignant glioma	6.52e-06	9.35e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EGF—malignant glioma	6.49e-06	9.31e-05	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—PIK3CA—malignant glioma	6.48e-06	9.3e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTPN11—malignant glioma	6.45e-06	9.25e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—NCOR1—malignant glioma	6.39e-06	9.16e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—NCOR1—malignant glioma	6.33e-06	9.08e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—BRAF—malignant glioma	6.28e-06	9e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—BRAF—malignant glioma	6.18e-06	8.85e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKT2—malignant glioma	6.11e-06	8.76e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PTEN—malignant glioma	6.1e-06	8.75e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—EGFR—malignant glioma	6.08e-06	8.72e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKT2—malignant glioma	6.01e-06	8.62e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CD—malignant glioma	6e-06	8.6e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—EGFR—malignant glioma	5.99e-06	8.58e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	5.98e-06	8.57e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PTEN—malignant glioma	5.92e-06	8.49e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—GSTP1—malignant glioma	5.89e-06	8.44e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CD—malignant glioma	5.87e-06	8.41e-05	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—PIK3CA—malignant glioma	5.81e-06	8.33e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	5.78e-06	8.28e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—KRAS—malignant glioma	5.75e-06	8.24e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CAT—malignant glioma	5.73e-06	8.22e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	5.72e-06	8.2e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PTEN—malignant glioma	5.69e-06	8.15e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—CAV1—malignant glioma	5.66e-06	8.12e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—KRAS—malignant glioma	5.65e-06	8.11e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—FGF2—malignant glioma	5.62e-06	8.06e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—FGF2—malignant glioma	5.53e-06	7.93e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—NCOR1—malignant glioma	5.41e-06	7.76e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.41e-06	7.76e-05	CbGpPWpGaD
Diphenhydramine—CYP2C18—Metabolism—AKT1—malignant glioma	5.3e-06	7.59e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	5.28e-06	7.57e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MDM2—malignant glioma	5.26e-06	7.54e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—RAF1—malignant glioma	5.24e-06	7.51e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CB—malignant glioma	5.23e-06	7.5e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—CAV1—malignant glioma	5.21e-06	7.47e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	5.2e-06	7.45e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—ERBB2—malignant glioma	5.18e-06	7.43e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTGS2—malignant glioma	5.18e-06	7.43e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MDM2—malignant glioma	5.17e-06	7.42e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—CAV1—malignant glioma	5.16e-06	7.4e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CG—malignant glioma	5.16e-06	7.39e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—RAF1—malignant glioma	5.16e-06	7.39e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CB—malignant glioma	5.12e-06	7.33e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—ERBB2—malignant glioma	5.1e-06	7.31e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	5.03e-06	7.22e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PPARG—malignant glioma	4.98e-06	7.14e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.93e-06	7.07e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CXCL8—malignant glioma	4.92e-06	7.05e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CXCL8—malignant glioma	4.84e-06	6.94e-05	CbGpPWpGaD
Diphenhydramine—HRH1—GPCR downstream signaling—AKT1—malignant glioma	4.75e-06	6.81e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CG—malignant glioma	4.74e-06	6.8e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—CASP3—malignant glioma	4.71e-06	6.75e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CG—malignant glioma	4.7e-06	6.74e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—IL2—malignant glioma	4.7e-06	6.74e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	4.67e-06	6.7e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—CASP3—malignant glioma	4.63e-06	6.64e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—IL2—malignant glioma	4.62e-06	6.63e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PPARG—malignant glioma	4.58e-06	6.56e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PPARG—malignant glioma	4.54e-06	6.51e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CD—malignant glioma	4.53e-06	6.5e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PTEN—malignant glioma	4.52e-06	6.48e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MMP9—malignant glioma	4.45e-06	6.37e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PTEN—malignant glioma	4.42e-06	6.34e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—CAV1—malignant glioma	4.41e-06	6.33e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MMP9—malignant glioma	4.38e-06	6.27e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PTEN—malignant glioma	4.35e-06	6.24e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling by GPCR—AKT1—malignant glioma	4.31e-06	6.18e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—PIK3CA—malignant glioma	4.3e-06	6.17e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling by GPCR—AKT1—malignant glioma	4.24e-06	6.08e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.22e-06	6.04e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—PIK3CA—malignant glioma	4.18e-06	5.99e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CD—malignant glioma	4.17e-06	5.98e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CD—malignant glioma	4.13e-06	5.93e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CG—malignant glioma	4.02e-06	5.76e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—PIK3CA—malignant glioma	4.01e-06	5.75e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—VEGFA—malignant glioma	3.99e-06	5.72e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—STAT3—malignant glioma	3.95e-06	5.67e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CB—malignant glioma	3.95e-06	5.67e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—VEGFA—malignant glioma	3.93e-06	5.63e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTGS2—malignant glioma	3.92e-06	5.61e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—STAT3—malignant glioma	3.89e-06	5.58e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PPARG—malignant glioma	3.88e-06	5.56e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—MYC—malignant glioma	3.67e-06	5.27e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CB—malignant glioma	3.64e-06	5.21e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—MYC—malignant glioma	3.62e-06	5.18e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CB—malignant glioma	3.6e-06	5.17e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTGS2—malignant glioma	3.6e-06	5.16e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—EGFR—malignant glioma	3.59e-06	5.15e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTGS2—malignant glioma	3.57e-06	5.12e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—EGFR—malignant glioma	3.54e-06	5.07e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CD—malignant glioma	3.53e-06	5.06e-05	CbGpPWpGaD
Diphenhydramine—SLC22A2—Metabolism—AKT1—malignant glioma	3.52e-06	5.04e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PTEN—malignant glioma	3.42e-06	4.9e-05	CbGpPWpGaD
Diphenhydramine—PTGS1—Metabolism—AKT1—malignant glioma	3.41e-06	4.89e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—KRAS—malignant glioma	3.39e-06	4.87e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—KRAS—malignant glioma	3.34e-06	4.79e-05	CbGpPWpGaD
Diphenhydramine—SLC22A1—Metabolism—AKT1—malignant glioma	3.28e-06	4.7e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—PIK3CA—malignant glioma	3.19e-06	4.57e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PTEN—malignant glioma	3.14e-06	4.5e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—PIK3CA—malignant glioma	3.12e-06	4.47e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PTEN—malignant glioma	3.11e-06	4.46e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CB—malignant glioma	3.08e-06	4.41e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	3.07e-06	4.4e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTGS2—malignant glioma	3.05e-06	4.37e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—TP53—malignant glioma	3.02e-06	4.33e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—TP53—malignant glioma	2.97e-06	4.26e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PTEN—malignant glioma	2.66e-06	3.81e-05	CbGpPWpGaD
Diphenhydramine—CYP2B6—Metabolism—AKT1—malignant glioma	2.6e-06	3.73e-05	CbGpPWpGaD
Diphenhydramine—HRH1—Signaling Pathways—AKT1—malignant glioma	2.55e-06	3.65e-05	CbGpPWpGaD
Diphenhydramine—CHRM2—Signaling Pathways—AKT1—malignant glioma	2.51e-06	3.59e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—PIK3CA—malignant glioma	2.41e-06	3.45e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.22e-06	3.18e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—PIK3CA—malignant glioma	2.2e-06	3.15e-05	CbGpPWpGaD
Diphenhydramine—CYP2C19—Metabolism—AKT1—malignant glioma	1.97e-06	2.82e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.88e-06	2.69e-05	CbGpPWpGaD
Diphenhydramine—CYP2D6—Metabolism—AKT1—malignant glioma	1.81e-06	2.6e-05	CbGpPWpGaD
Diphenhydramine—CYP2C9—Metabolism—AKT1—malignant glioma	1.79e-06	2.57e-05	CbGpPWpGaD
Diphenhydramine—CYP1A2—Metabolism—AKT1—malignant glioma	1.53e-06	2.2e-05	CbGpPWpGaD
